# Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer.

> clinical trial · VERIFIED · 2026-07-28

Status: NOT_YET_RECRUITING · Sponsor: RenJi Hospital · Condition: Prostate Cancer

- Company: RenJi Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07730151

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.